FDA Inspection 1207736 — CMIC CMO USA Corporation

CMIC CMO USA Corporation — FEI 3001237056

The FDA completed an inspection of CMIC CMO USA Corporation on March 31, 2023 in Cranbury, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 31, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cranbury, NJ (United States)